Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	HIPK3 ARID1B CAMTA2 MAML2 RAD54L2 MED1 TCF20 BCL9 BCOR MRTFA	3.02e-07	562	44	10	GO:0003712
GeneOntologyMolecularFunction	transcription coactivator activity	ARID1B CAMTA2 MAML2 MED1 TCF20 BCL9 MRTFA	4.09e-06	303	44	7	GO:0003713
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	HIPK3 ARID1B CAMTA2 MAML2 RAD54L2 SHANK2 MED1 TCF20 BCL9 BCOR MRTFA	3.15e-05	1160	44	11	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	HIPK3 ARID1B CAMTA2 MAML2 RAD54L2 SHANK2 MED1 TCF20 BCL9 BCOR MRTFA	1.30e-04	1356	44	11	GO:0060090
MousePheno	stereotypic behavior	KCNMA1 ARID1B CHD7 SHANK2 TCF20 ACHE	1.59e-05	214	36	6	MP:0001408
MousePheno	abnormal vocalization	ARID1B SHANK2 TCF20 AARS2 ACHE ARAP1	2.84e-05	237	36	6	MP:0001529
MousePheno	decreased susceptibility to noise-induced hearing loss	KCNMA1 CHD7	3.86e-05	4	36	2	MP:0004925
MousePheno	decreased pulmonary ventilation	SPATA6 ACHE ARAP1	1.35e-04	39	36	3	MP:0005576
MousePheno	decreased body length	TNRC6B ARID1B CHD7 ALDH1A2 TCF20 MBD6 SAMD4A	1.99e-04	484	36	7	MP:0001258
MousePheno	circling	KCNMA1 CHD7 TCF20 ACHE	2.23e-04	117	36	4	MP:0001394
MousePheno	abnormal forebrain development	CHD7 LHX8 MED1 TCF20 BCOR	2.59e-04	225	36	5	MP:0003232
MousePheno	abnormal telencephalon development	CHD7 LHX8 MED1 TCF20	2.96e-04	126	36	4	MP:0000934
MousePheno	postnatal lethality	TINAGL1 CHD7 ALDH1A2 LHX8 SHANK2 TCF20 CBL CIT FOXN4 ACHE	2.97e-04	1084	36	10	MP:0002082
MousePheno	increased stereotypic behavior	ARID1B SHANK2 TCF20	3.36e-04	53	36	3	MP:0001409
MousePheno	fusion of glossopharyngeal and vagus nerve	CHD7 ALDH1A2	3.50e-04	11	36	2	MP:0004568
MousePheno	abnormal pulmonary ventilation	SPATA6 ACHE ARAP1	3.55e-04	54	36	3	MP:0002338
Domain	SAM_1	SHANK2 ARAP1 SAMD4A	5.13e-04	68	43	3	PF00536
Domain	SAM	SHANK2 ARAP1 SAMD4A	1.09e-03	88	43	3	SM00454
Domain	SAM_DOMAIN	SHANK2 ARAP1 SAMD4A	1.36e-03	95	43	3	PS50105
Domain	SAM	SHANK2 ARAP1 SAMD4A	1.44e-03	97	43	3	IPR001660
Domain	-	SHANK2 ARAP1 SAMD4A	1.86e-03	106	43	3	1.10.150.50
Domain	SNF2_N	CHD7 RAD54L2	2.46e-03	32	43	2	IPR000330
Domain	SNF2_N	CHD7 RAD54L2	2.46e-03	32	43	2	PF00176
Domain	SAM/pointed	SHANK2 ARAP1 SAMD4A	2.46e-03	117	43	3	IPR013761
Domain	UBA-like	TNRC6B CBL	9.54e-03	64	43	2	IPR009060
Pathway	REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1	CBL ARAP1	1.46e-04	9	29	2	M27732
Pathway	REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1	CBL ARAP1	1.46e-04	9	29	2	MM15482
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ARID1B CHD7 MED1 TCF20 BCL9 BCOR	1.53e-09	83	47	6	28794006
Pubmed	Interaction network of human early embryonic transcription factors.	ARID1B CHD7 RAD54L2 TCF20 BCL9 MBD6 BCOR MGA	2.22e-08	351	47	8	38297188
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	ARID1B CHD7 MED1 TCF20 BCOR	7.10e-08	78	47	5	28611094
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ARID1B CHD7 MED1 TCF20 BCL9 BCOR MGA	7.21e-08	268	47	7	33640491
Pubmed	Human transcription factor protein interaction networks.	TNRC6B NOL4L ARID1B CHD7 RAD54L2 LHX8 TCF20 BCL9 MBD6 BCOR MGA CIT	3.04e-07	1429	47	12	35140242
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TNRC6B NOL4L CHD7 TCF20 BCOR MGA MRTFA	1.43e-06	418	47	7	34709266
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	CHD7 MAML2 RAD54L2 BCL9 MGA MRTFA ARAP1	1.73e-06	430	47	7	35044719
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	RAD54L2 TCF20 BCL9 BCOR RAVER2	4.52e-06	180	47	5	35198878
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KCNMA1 TNRC6B CHD7 SHANK2 TCF20 BCL9 BCOR MGA CIT	4.88e-06	963	47	9	28671696
Pubmed	Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.	CBL ARAP1	5.36e-06	3	47	2	29589748
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TNRC6B ARID1B MED1 TCF20 BCOR CBL MGA	8.56e-06	549	47	7	38280479
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	HIPK3 FAM193B CHD7 SHANK2 AARS2 TTLL5 ENTPD1	8.87e-06	552	47	7	10737800
Pubmed	A noncanonical SH3 domain binding motif links BK channels to the actin cytoskeleton via the SH3 adapter cortactin.	KCNMA1 GRAP2	1.07e-05	4	47	2	17065230
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NOL4L ARID1B CHD7 RAD54L2 MED1 TCF20 BCL9 BCOR CIT	1.45e-05	1103	47	9	34189442
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	CHD7 TCF20 BCOR MGA	1.47e-05	109	47	4	33554859
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ARID1B CHD7 TCF20 BCOR AARS2 MGA	1.56e-05	398	47	6	35016035
Pubmed	Loss of forebrain cholinergic neurons and impairment in spatial learning and memory in LHX7-deficient mice.	LHX8 ACHE	1.78e-05	5	47	2	15978004
Pubmed	Expression of the Grb2-related protein of the lymphoid system in B cell subsets enhances B cell antigen receptor signaling through mitogen-activated protein kinase pathways.	CBL GRAP2	1.78e-05	5	47	2	12496419
Pubmed	Differential recruitment of E3 ubiquitin ligase complexes regulates RET isoform internalization.	SHANK2 CBL	1.78e-05	5	47	2	28794017
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARID1B CHD7 MED1 TCF20 BCL9 BCOR CBL	2.25e-05	638	47	7	31182584
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	TNRC6B ARID1B TCF20 BCOR	2.36e-05	123	47	4	26912792
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIPK3 KCNMA1 TNRC6B EP400P1 TANC1 H6PD SHANK2 SPATA6 ARAP1 ENTPD1	2.44e-05	1489	47	10	28611215
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ARID1B MED1 TCF20 MGA	3.30e-05	134	47	4	25452129
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TNRC6B ARID1B TCF20 BCL9 BCOR RAVER2	3.39e-05	457	47	6	32344865
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	TNRC6B ARID1B TANC1 MED1 TCF20 MRTFA	4.06e-05	472	47	6	38943005
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNRC6B ARID1B PRR14L CHD7 TANC1 TCF20 MGA	5.42e-05	733	47	7	34672954
Pubmed	Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.	ARID1B MAML2	6.40e-05	9	47	2	19176441
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NOL4L CHD7 MED1 TCF20 BCL9 BCOR MRTFA	7.63e-05	774	47	7	15302935
Pubmed	Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.	CBL GRAP2	9.75e-05	11	47	2	9872323
Pubmed	Orphan nuclear receptor Nurr1 is essential for Ret expression in midbrain dopamine neurons and in the brain stem.	ALDH1A2 ACHE	9.75e-05	11	47	2	11749040
Pubmed	The LIM-homeobox gene Islet-1 is required for the development of restricted forebrain cholinergic neurons.	LHX8 ACHE	9.75e-05	11	47	2	18367596
Pubmed	A genome-wide association study of northwestern Europeans involves the C-type natriuretic peptide signaling pathway in the etiology of human height variation.	TNRC6B MRTFA	9.75e-05	11	47	2	19570815
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TINAGL1 FAM193B TANC1 SHANK2 BCL9 MBD6 CIT ARAP1	1.06e-04	1105	47	8	35748872
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	TNRC6B BCOR MGA TTLL5	1.13e-04	184	47	4	32908313
Pubmed	The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1.	LHX8 ACHE	1.38e-04	13	47	2	22098391
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	TNRC6B TANC1 MGA CIT MRTFA	1.56e-04	378	47	5	34315543
Pubmed	Three human ARX mutations cause the lissencephaly-like and mental retardation with epilepsy-like pleiotropic phenotypes in mice.	LHX8 ACHE	1.86e-04	15	47	2	19605412
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNRC6B CHD7 MRTFA ARAP1	2.45e-04	225	47	4	12168954
Pubmed	Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.	TNRC6B MRTFA	3.01e-04	19	47	2	25342443
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TNRC6B RAD54L2 MED1 BCOR MGA	3.27e-04	444	47	5	34795231
Pubmed	Quantitative interactomics in primary T cells unveils TCR signal diversification extent and dynamics.	CBL ARAP1	3.34e-04	20	47	2	31591574
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ARID1B RAD54L2 MED1 TCF20 MGA	3.59e-04	453	47	5	29656893
Pubmed	Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TNRC6B SHANK2 SAMD4A	3.83e-04	104	47	3	10470851
Pubmed	Reduced endothelin converting enzyme-1 and endothelin-3 mRNA in the developing bowel of male mice may increase expressivity and penetrance of Hirschsprung disease-like distal intestinal aganglionosis.	ALDH1A2 ACHE	4.84e-04	24	47	2	17131407
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CHD7 MED1 TCF20 MGA	5.81e-04	283	47	4	30585729
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NOL4L ARID1B CHD7 CAMTA2 BCOR MGA MRTFA	5.93e-04	1084	47	7	11544199
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	CHD7 RAD54L2 MGA	6.55e-04	125	47	3	32891193
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TNRC6B EP400P1 ARID1B TANC1 BCOR MGA GRAP2	7.05e-04	1116	47	7	31753913
Pubmed	The DNA sequence of human chromosome 22.	TNRC6B TCF20 MRTFA GRAP2	7.23e-04	300	47	4	10591208
Pubmed	Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.	CBL GRAP2	7.59e-04	30	47	2	12522270
Pubmed	GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease.	TANC1 MAML2	9.19e-04	33	47	2	21658281
Pubmed	Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1.	ALDH1A2 FOXN4	9.19e-04	33	47	2	18662545
Pubmed	Microphthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	CHD7 BCOR	9.75e-04	34	47	2	20301552
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	CHD7 BCOR MGA	1.03e-03	146	47	3	23892456
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	TNRC6B BCL9 BCOR	1.15e-03	152	47	3	38360978
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	CHD7 TANC1 ALDH1A2 RAD54L2 BCOR	1.16e-03	588	47	5	38580884
Pubmed	PRC1 sustains the integrity of neural fate in the absence of PRC2 function.	ALDH1A2 LHX8	1.22e-03	38	47	2	34994686
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	ARID1B CHD7 MBD6	1.26e-03	157	47	3	30186101
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	TNRC6B FAM193B RAD54L2 MBD6 BCOR	1.34e-03	608	47	5	16713569
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CHD7 MED1 TCF20 BCOR MGA	1.34e-03	608	47	5	36089195
Interaction	FEV interactions	ARID1B CHD7 RAD54L2 TCF20 BCL9 BCOR MGA	3.64e-07	203	46	7	int:FEV
Interaction	PAX2 interactions	ARID1B CHD7 BCL9 BCOR MGA	1.42e-06	85	46	5	int:PAX2
Interaction	IRF4 interactions	ARID1B CHD7 TCF20 BCOR CBL	1.42e-06	85	46	5	int:IRF4
Interaction	EGR2 interactions	ARID1B CHD7 RAD54L2 BCL9 BCOR MGA	2.42e-06	171	46	6	int:EGR2
Interaction	SOX17 interactions	ARID1B CHD7 TCF20 BCL9 BCOR	2.46e-06	95	46	5	int:SOX17
Interaction	ALG13 interactions	TNRC6B ARID1B TCF20 BCL9 BCOR RAVER2	3.58e-06	183	46	6	int:ALG13
Interaction	LHX2 interactions	ARID1B CHD7 BCL9 BCOR MGA MRTFA	3.58e-06	183	46	6	int:LHX2
Interaction	LHX3 interactions	ARID1B CHD7 TCF20 BCL9 BCOR MGA	3.81e-06	185	46	6	int:LHX3
Interaction	GATA3 interactions	TINAGL1 ARID1B CHD7 MED1 BCL9 BCOR	4.05e-06	187	46	6	int:GATA3
Interaction	HNF1B interactions	ARID1B CHD7 BCL9 MBD6 BCOR MGA	4.44e-06	190	46	6	int:HNF1B
Interaction	PAX8 interactions	ARID1B CHD7 BCL9 BCOR CIT	5.30e-06	111	46	5	int:PAX8
Interaction	SP7 interactions	ARID1B CHD7 TCF20 BCL9 BCOR CBL MGA	5.36e-06	304	46	7	int:SP7
Interaction	TBXT interactions	ARID1B CHD7 TCF20 BCL9 BCOR	6.58e-06	116	46	5	int:TBXT
Interaction	ERG interactions	ARID1B CHD7 RAD54L2 TCF20 BCL9 BCOR	1.11e-05	223	46	6	int:ERG
Interaction	PAX9 interactions	ARID1B CHD7 TCF20 BCL9 BCOR	1.15e-05	130	46	5	int:PAX9
Interaction	TLX2 interactions	ARID1B CHD7 TCF20 BCL9 BCOR	1.76e-05	142	46	5	int:TLX2
Interaction	TLE3 interactions	ARID1B RAD54L2 TCF20 BCL9 BCOR CBL RAVER2	2.13e-05	376	46	7	int:TLE3
Interaction	HNF4A interactions	ARID1B CHD7 RAD54L2 MED1 BCOR MGA	3.62e-05	275	46	6	int:HNF4A
Interaction	SOX7 interactions	ARID1B CHD7 TCF20 BCOR	3.65e-05	82	46	4	int:SOX7
Interaction	GATA1 interactions	ARID1B MED1 BCL9 BCOR GRAP2	4.29e-05	171	46	5	int:GATA1
Interaction	TLX1 interactions	ARID1B CHD7 TCF20 BCL9 BCOR	4.79e-05	175	46	5	int:TLX1
Interaction	TEAD1 interactions	ARID1B CHD7 BCOR MGA CIT	4.92e-05	176	46	5	int:TEAD1
Interaction	AR interactions	HIPK3 ARID1B CHD7 RAD54L2 MED1 TCF20 BCL9 BCOR MGA GRAP2	6.44e-05	992	46	10	int:AR
Interaction	GATA2 interactions	ARID1B CHD7 MED1 BCL9 BCOR	8.81e-05	199	46	5	int:GATA2
Interaction	LHX1 interactions	ARID1B CHD7 BCL9 MGA	8.90e-05	103	46	4	int:LHX1
Interaction	ZYX interactions	HIPK3 TNRC6B TANC1 CBL CIT MRTFA	9.77e-05	329	46	6	int:ZYX
Interaction	TBR1 interactions	ARID1B CHD7 BCL9 BCOR	1.28e-04	113	46	4	int:TBR1
Interaction	CDK2AP1 interactions	TCF20 BCOR CBL CIT	1.51e-04	118	46	4	int:CDK2AP1
Interaction	PPIA interactions	KCNMA1 TNRC6B ARID1B TANC1 MED1 TCF20 MBD6 CIT MRTFA	1.52e-04	888	46	9	int:PPIA
Interaction	KLF3 interactions	ARID1B LHX8 MBD6 BCOR MGA	1.67e-04	228	46	5	int:KLF3
Interaction	COL4A1 interactions	HABP2 CBL ACHE	1.79e-04	48	46	3	int:COL4A1
Interaction	PAX7 interactions	ARID1B CHD7 BCL9 BCOR	1.82e-04	124	46	4	int:PAX7
Interaction	TRIM52 interactions	PRR14L TANC1 MGA TTLL5	2.39e-04	133	46	4	int:TRIM52
Interaction	ASF1A interactions	ARID1B CHD7 TCF20 BCOR MGA	2.51e-04	249	46	5	int:ASF1A
Interaction	CRX interactions	ARID1B CHD7 TCF20 BCL9 MGA	2.75e-04	254	46	5	int:CRX
Interaction	HOMER1 interactions	TANC1 RAD54L2 SHANK2 CIT	2.90e-04	140	46	4	int:HOMER1
Interaction	NUP35 interactions	TNRC6B ARID1B TCF20 BCL9 BCOR RAVER2	3.85e-04	424	46	6	int:NUP35
Interaction	HSPA2 interactions	KCNMA1 ARID1B CBL CIT TTLL5 MRTFA	4.68e-04	440	46	6	int:HSPA2
Interaction	FBLN5 interactions	ARID1B PRR14L RAD54L2 TTLL5	4.70e-04	159	46	4	int:FBLN5
Interaction	BAG2 interactions	PRR14L TCF20 BCOR CBL CIT MRTFA RAVER2	4.85e-04	622	46	7	int:BAG2
Interaction	NUP43 interactions	TNRC6B ARID1B RAD54L2 TCF20 BCOR MGA CIT	4.99e-04	625	46	7	int:NUP43
Interaction	GCM1 interactions	ARID1B BCL9 BCOR	5.03e-04	68	46	3	int:GCM1
Interaction	TLX3 interactions	ARID1B CHD7 TCF20 BCL9 BCOR	5.12e-04	291	46	5	int:TLX3
Interaction	LHX4 interactions	ARID1B CHD7 BCL9 MGA	5.53e-04	166	46	4	int:LHX4
Interaction	SNRNP40 interactions	ARID1B TCF20 BCL9 BCOR MGA CIT RAVER2	5.59e-04	637	46	7	int:SNRNP40
Interaction	TWIST1 interactions	CHD7 TCF20 BCOR MGA	6.05e-04	170	46	4	int:TWIST1
Interaction	CBX3 interactions	CHD7 RAD54L2 MED1 TCF20 BCOR MGA CIT	6.07e-04	646	46	7	int:CBX3
Interaction	B9D2 interactions	TNRC6B ARID1B BCOR	6.19e-04	73	46	3	int:B9D2
Interaction	FIGLA interactions	TINAGL1 LHX8	6.78e-04	17	46	2	int:FIGLA
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	TNRC6B TCF20 MRTFA GRAP2	3.66e-04	330	47	4	chr22q13
GeneFamily	Sterile alpha motif domain containing	SHANK2 ARAP1 SAMD4A	2.67e-04	88	26	3	760
GeneFamily	Ankyrin repeat domain containing	TANC1 SHANK2 BCOR ARAP1	3.71e-04	242	26	4	403
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	KCNMA1 TNRC6B ARID1B MAML2 SHANK2	2.12e-06	199	47	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Globus_pallidus\|World / BrainAtlas - Mouse McCarroll V32	FAM193B DCHS2 LHX8 MBD6	9.53e-06	126	47	4	44b63f945d5bedf1a2ca1810e7e100276ea9dd89
ToppCell	(09)_Ionocytes\|World / shred by cell type and Timepoint	KCNMA1 RAVER2 ENTPD1 PPP1R1A	1.25e-05	135	47	4	237b9b646513ca6e4b754c0da95d24015b3661f7
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TINAGL1 SHANK2 ACHE SAMD4A	2.50e-05	161	47	4	0d863d7d369391dd6148e1de6d6f8033dcb8fe0f
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TANC1 CAMTA2 MAML2 SAMD4A	3.02e-05	169	47	4	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TANC1 CAMTA2 MAML2 SAMD4A	3.02e-05	169	47	4	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAGL1 NOL4L ALDH1A2 SPATA6	3.46e-05	175	47	4	98dc3b6f69a29d587f503898f09912700950e3d9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.03e-05	182	47	4	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.03e-05	182	47	4	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.03e-05	182	47	4	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.03e-05	182	47	4	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.30e-05	185	47	4	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.30e-05	185	47	4	7aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.30e-05	185	47	4	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 TANC1 MAML2 SPATA6	4.30e-05	185	47	4	2e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	KCNMA1 TANC1 MAML2 TCF20	4.58e-05	188	47	4	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	4.77e-05	190	47	4	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	COVID-19-kidney-Mito-rich_Distal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SHANK2 CIT TMEM72 PPP1R1A	4.87e-05	191	47	4	0965f621ebcd92ccdeb21cc27022180ce3cfe910
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TNRC6B ARID1B MAML2 SHANK2	4.97e-05	192	47	4	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.07e-05	193	47	4	4aa976b596830b585e8d9c808d5072ed23d13a7c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.07e-05	193	47	4	5578f7cb3ec68c9a38cc5304b618b81283024d5e
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.07e-05	193	47	4	5ec917931b438dd0e7fb03eb6af459d3ef6b84ba
ToppCell	368C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.07e-05	193	47	4	5260ac95a15cc43a19909badad0c7e3854da920d
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	MED1 BCL9 BCOR MGA	5.07e-05	193	47	4	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	TANC1 CAMTA2 MAML2 SAMD4A	5.17e-05	194	47	4	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	TANC1 CAMTA2 MAML2 SAMD4A	5.17e-05	194	47	4	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	ARID1B MAML2 SPATA6 MRTFA	5.27e-05	195	47	4	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ARID1B MAML2 SPATA6 MRTFA	5.38e-05	196	47	4	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.49e-05	197	47	4	ba6393671a980a1d439307601d18db70a1b1e1f3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 KCNMA1 ENTPD1 PPP1R1A	5.49e-05	197	47	4	f4f686d20821af3e6f859b96edc31827a430e3de
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARID1B TANC1 MAML2 SHANK2	5.60e-05	198	47	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	mild-Non-classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KCNMA1 SPATA6 CBL ARAP1	5.82e-05	200	47	4	334bab6bf93d455f3526e817ea5785d8b6ee531c
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KCNMA1 TANC1 SHANK2 RAVER2	5.82e-05	200	47	4	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
Drug	Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A	KCNMA1 DCHS2 HABP2 H6PD CBL TTLL5	2.73e-06	197	46	6	3188_UP
Drug	perindoprilat	ACHE ENTPD1 PPP1R1A	1.52e-05	24	46	3	CID000072022
Drug	Argentine	PRNT TANC1 F8	4.04e-05	33	46	3	CID000442941
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; MCF7; HT_HG-U133A	HIPK3 PRR14L H6PD CBL ENTPD1	4.09e-05	191	46	5	2824_UP
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	HIPK3 MED1 TTLL5 MRTFA ARAP1	4.40e-05	194	46	5	3377_DN
Drug	Benzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A	KCNMA1 TNRC6B BCL9 MRTFA ARAP1	4.40e-05	194	46	5	6070_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; MCF7; HT_HG-U133A	BCL9 TTLL5 MRTFA ENTPD1 SAMD4A	4.51e-05	195	46	5	3583_DN
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 TNRC6B SHANK2 CBL	4.62e-05	196	46	5	2310_UP
Drug	Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A	KCNMA1 H6PD RAD54L2 SHANK2 SPATA6	4.62e-05	196	46	5	2800_UP
Drug	CAY10397; Up 200; 10uM; PC3; HT_HG-U133A	CHD7 CAMTA2 H6PD MED1 ENTPD1	4.62e-05	196	46	5	7071_UP
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 TNRC6B MRTFA SAMD4A	4.62e-05	196	46	5	2301_UP
Drug	Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A	HIPK3 RAD54L2 CBL MRTFA ENTPD1	4.74e-05	197	46	5	7458_UP
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HIPK3 RAD54L2 TTLL5 MRTFA ARAP1	4.74e-05	197	46	5	3934_DN
Drug	Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 CBL TTLL5 SAMD4A	4.74e-05	197	46	5	3933_DN
Drug	Cefaclor [70356-03-5]; Up 200; 10.4uM; PC3; HT_HG-U133A	HIPK3 SHANK2 SPATA6 ACHE SAMD4A	4.74e-05	197	46	5	6622_UP
Drug	Levamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; PC3; HT_HG-U133A	HIPK3 TNRC6B SHANK2 MRTFA ENTPD1	4.85e-05	198	46	5	2094_UP
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	HIPK3 CBL TTLL5 ARAP1 ENTPD1	4.85e-05	198	46	5	2411_DN
Drug	Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A	HIPK3 HABP2 SHANK2 SPATA6 SAMD4A	4.85e-05	198	46	5	6611_UP
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HIPK3 H6PD RAD54L2 SPATA6 ENTPD1	4.85e-05	198	46	5	5003_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	H6PD CBL MRTFA ENTPD1 SAMD4A	4.85e-05	198	46	5	6043_DN
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	PRR14L CAMTA2 BCOR TTLL5 ARAP1	4.85e-05	198	46	5	2799_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HT_HG-U133A	HIPK3 SPATA6 CBL ACHE SAMD4A	4.97e-05	199	46	5	6631_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	HIPK3 KCNMA1 H6PD TTLL5 SAMD4A	4.97e-05	199	46	5	5731_UP
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A	H6PD SHANK2 BCOR TTLL5 ENTPD1	4.97e-05	199	46	5	6355_DN
Drug	Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	TTLL5 MRTFA RAVER2 ENTPD1 SAMD4A	4.97e-05	199	46	5	3640_UP
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; HL60; HT_HG-U133A	PRR14L H6PD RAD54L2 MRTFA ARAP1	5.09e-05	200	46	5	2939_DN
Drug	demeton-S-methyl	H6PD ACHE	8.33e-05	7	46	2	CID000013526
Drug	AC1L1RTV	KCNMA1 ACHE	8.33e-05	7	46	2	CID000008854
Drug	TMPH	KCNMA1 ACHE	8.33e-05	7	46	2	CID000015383
Drug	PHMPS	ACHE ENTPD1	1.11e-04	8	46	2	CID003033937
Drug	CID9572852	TCF20 ACHE	1.11e-04	8	46	2	CID009572852
Drug	methyl parathion	H6PD CIT ACHE	1.33e-04	49	46	3	CID000004130
Drug	aminocarb	KCNMA1 ACHE	1.42e-04	9	46	2	CID000016247
Drug	triazophos	H6PD ACHE	2.60e-04	12	46	2	CID000032184
Drug	light green	CBL TTLL5	2.60e-04	12	46	2	CID000006727
Drug	pinene	CIT ACHE	3.07e-04	13	46	2	CID000014896
Drug	CEP-7055	F8 GRAP2	3.07e-04	13	46	2	CID000216386
Drug	methiocarb	KCNMA1 H6PD	3.58e-04	14	46	2	CID000016248
Drug	succinic semialdehyde	ALDH1A2 SHANK2 TCF20	3.68e-04	69	46	3	CID000001112
Drug	acryloyl chloride	ACHE F8	4.12e-04	15	46	2	CID000013140
Drug	p-chloro-N-methylaniline	H6PD ACHE	4.12e-04	15	46	2	CID000070272
Drug	Vydate	SHANK2 ACHE	4.12e-04	15	46	2	CID000031657
Drug	fenamiphos	SHANK2 ACHE	4.71e-04	16	46	2	CID000031070
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HT_HG-U133A	HIPK3 SPATA6 CBL SAMD4A	5.17e-04	184	46	4	4205_UP
Drug	AC1L6DV2	H6PD PPP1R1A	5.33e-04	17	46	2	CID000290482
Drug	cyclooctane	KCNMA1 ACHE	5.33e-04	17	46	2	CID000009266
Drug	Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SHANK2 TTLL5 ARAP1 ENTPD1	5.38e-04	186	46	4	6051_DN
Drug	Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 MRTFA ENTPD1	5.60e-04	188	46	4	5442_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	TINAGL1 H6PD RAD54L2 MED1	5.72e-04	189	46	4	6649_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 RAD54L2 ARAP1	5.83e-04	190	46	4	3966_DN
Drug	Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	RAD54L2 BCL9 ARAP1 ENTPD1	6.06e-04	192	46	4	4152_DN
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A	KCNMA1 TNRC6B H6PD CBL	6.18e-04	193	46	4	4286_DN
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; MCF7; HT_HG-U133A	H6PD MRTFA ARAP1 ENTPD1	6.18e-04	193	46	4	3200_DN
Drug	Levodopa [59-92-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A	HIPK3 PRR14L MRTFA ARAP1	6.18e-04	193	46	4	4394_DN
Drug	Beta-sistosterol [83-46-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	HIPK3 TNRC6B SHANK2 BCL9	6.18e-04	193	46	4	4154_DN
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	H6PD BCOR MRTFA ARAP1	6.18e-04	193	46	4	6949_UP
Drug	Melatonin [73-31-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A	PRR14L TTLL5 MRTFA SAMD4A	6.18e-04	193	46	4	3293_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A	KCNMA1 RAD54L2 TTLL5 MRTFA	6.30e-04	194	46	4	3969_DN
Drug	Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A	KCNMA1 MRTFA ARAP1 SAMD4A	6.30e-04	194	46	4	3938_DN
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	PRR14L H6PD RAD54L2 ENTPD1	6.30e-04	194	46	4	1480_DN
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; PC3; HT_HG-U133A	TINAGL1 RAD54L2 CBL ARAP1	6.30e-04	194	46	4	5776_DN
Drug	Ergocryptine-alpha [511-09-1]; Up 200; 7uM; PC3; HT_HG-U133A	TINAGL1 HABP2 SPATA6 MRTFA	6.30e-04	194	46	4	4552_UP
Drug	pemirolast	ALDH1A2 MGA FOXN4	6.33e-04	83	46	3	CID000057697
Drug	Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIPK3 PRR14L RAD54L2 MRTFA	6.43e-04	195	46	4	4358_DN
Drug	Mecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A	RAD54L2 TTLL5 ENTPD1 SAMD4A	6.43e-04	195	46	4	3525_DN
Drug	Bacitracin [1405-87-4]; Up 200; 2.8uM; MCF7; HT_HG-U133A	RAD54L2 ARAP1 ENTPD1 SAMD4A	6.43e-04	195	46	4	7448_UP
Drug	Tiaprofenic acid [33005-95-7]; Down 200; 15.4uM; MCF7; HT_HG-U133A	RAD54L2 BCL9 ARAP1 ENTPD1	6.43e-04	195	46	4	2852_DN
Drug	Dapsone [80-08-0]; Down 200; 16.2uM; PC3; HT_HG-U133A	TINAGL1 CBL TTLL5 ARAP1	6.43e-04	195	46	4	5078_DN
Drug	ikarugamycin; Up 200; 2uM; MCF7; HT_HG-U133A_EA	F8 TTLL5 MRTFA SAMD4A	6.43e-04	195	46	4	866_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	CBL TTLL5 ARAP1 RAVER2	6.43e-04	195	46	4	2875_UP
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A	RAD54L2 CBL TTLL5 MRTFA	6.43e-04	195	46	4	4597_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	TINAGL1 RAD54L2 ARAP1 SAMD4A	6.55e-04	196	46	4	4292_DN
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 MRTFA ENTPD1	6.55e-04	196	46	4	4172_DN
Drug	LY 294002; Down 200; 0.1uM; PC3; HT_HG-U133A	CAMTA2 BCL9 TTLL5 ARAP1	6.55e-04	196	46	4	1216_DN
Drug	Chenodiol [474-25-9]; Up 200; 10.2uM; PC3; HT_HG-U133A	HIPK3 KCNMA1 CBL ENTPD1	6.55e-04	196	46	4	7310_UP
Drug	Pyrithyldione [77-04-3]; Up 200; 24uM; HL60; HT_HG-U133A	TINAGL1 KCNMA1 ALDH1A2 PPP1R1A	6.55e-04	196	46	4	2740_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	HIPK3 KCNMA1 MRTFA ARAP1	6.55e-04	196	46	4	5011_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A	HIPK3 ALDH1A2 BCL9 TTLL5	6.55e-04	196	46	4	7225_UP
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A	TINAGL1 CAMTA2 MED1 TTLL5	6.55e-04	196	46	4	2066_DN
Drug	Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; PC3; HT_HG-U133A	HIPK3 SHANK2 CBL ENTPD1	6.55e-04	196	46	4	6760_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	FAM193B CAMTA2 RAD54L2 ARAP1	6.55e-04	196	46	4	5232_UP
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A	HIPK3 TNRC6B CAMTA2 CBL	6.55e-04	196	46	4	5091_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A	SHANK2 MRTFA ARAP1 SAMD4A	6.55e-04	196	46	4	6462_DN
Drug	Pregnenolone [145-13-1]; Down 200; 12.6uM; MCF7; HT_HG-U133A	CAMTA2 RAD54L2 BCL9 TTLL5	6.55e-04	196	46	4	4802_DN
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A	KCNMA1 TNRC6B CHD7 ARAP1	6.55e-04	196	46	4	4296_DN
Drug	Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A	HIPK3 H6PD MED1 ARAP1	6.55e-04	196	46	4	1494_DN
Drug	Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HT_HG-U133A	HIPK3 ALDH1A2 CBL SAMD4A	6.55e-04	196	46	4	6615_UP
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	TNRC6B CAMTA2 MRTFA ARAP1	6.55e-04	196	46	4	3383_DN
Drug	Alclometasone dipropionate [667634-13-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A	TTLL5 MRTFA ARAP1 ENTPD1	6.55e-04	196	46	4	6229_UP
Drug	Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A	TNRC6B RAD54L2 TTLL5 ENTPD1	6.55e-04	196	46	4	2249_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RAD54L2 MRTFA ARAP1 ENTPD1	6.55e-04	196	46	4	2232_DN
Drug	Lovastatin [75330-75-5]; Up 200; 9.8uM; PC3; HT_HG-U133A	ALDH1A2 SPATA6 CBL MRTFA	6.55e-04	196	46	4	6633_UP
Drug	Flurbiprofen [5104-49-4]; Up 200; 16.4uM; PC3; HT_HG-U133A	CBL ACHE ARAP1 PPP1R1A	6.68e-04	197	46	4	4674_UP
Drug	Isopropamide iodide [71-81-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A	RAD54L2 MRTFA ENTPD1 SAMD4A	6.68e-04	197	46	4	6781_DN
Drug	Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A	KCNMA1 TTLL5 MRTFA ENTPD1	6.68e-04	197	46	4	4158_DN
Drug	Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	RAD54L2 TTLL5 MRTFA ARAP1	6.68e-04	197	46	4	2376_DN
Drug	Thiethylperazine malate [52239-63-1]; Down 200; 6uM; MCF7; HT_HG-U133A	FAM193B PRR14L CHD7 TTLL5	6.68e-04	197	46	4	6232_DN
Drug	Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A	HIPK3 RAD54L2 MRTFA ENTPD1	6.68e-04	197	46	4	4955_UP
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	TINAGL1 KCNMA1 TTLL5 ARAP1	6.68e-04	197	46	4	5835_UP
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; PC3; HT_HG-U133A	DCHS2 ALDH1A2 MED1 ACHE	6.68e-04	197	46	4	6674_UP
Disease	Growth Disorders	KCNMA1 CBL ACHE	2.44e-05	36	46	3	C0018273
Disease	Thrombophilia	HABP2 F8	8.50e-05	9	46	2	C0398623
Disease	autism spectrum disorder (implicated_via_orthology)	ARID1B CHD7 SHANK2 TCF20	9.33e-05	152	46	4	DOID:0060041 (implicated_via_orthology)
Disease	osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty	KCNMA1 MAML2	4.90e-04	21	46	2	EFO_0004616, EFO_0010726, EFO_1000786
Disease	C-reactive protein measurement	DCHS2 CHD7 ALDH1A2 CBL KIAA2012 CIT ARAP1 RAVER2	4.98e-04	1206	46	8	EFO_0004458
Disease	central nervous system cancer, glioma	MAML2 RAVER2	9.40e-04	29	46	2	EFO_0000326, EFO_0005543
Disease	mean platelet volume	NOL4L CHD7 MAML2 BCOR MRTFA ARAP1 GRAP2	9.52e-04	1020	46	7	EFO_0004584
Disease	cortical surface area measurement	TINAGL1 TNRC6B DCHS2 NOL4L ARID1B CHD7 ALDH1A2 MBD6	1.02e-03	1345	46	8	EFO_0010736
Disease	microcephaly (implicated_via_orthology)	AARS2 CIT	1.14e-03	32	46	2	DOID:10907 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
MRPPQCLLHTPSLAS	ACHE	1	P22303
PAALMASLHLLPSPT	ALDH1A2	16	O94788
TRHLAPQADPRPSMS	CAMTA2	341	O94983
SSHPALSQSPMPQER	ARID1B	846	Q8NFD5
MPPVSLNHNLTTPFT	RAD54L2	1296	Q9Y4B4
HIPSSLASPMRLSTP	BCOR	256	Q6W2J9
SHVPQQSPSMAPSLR	CHD7	236	Q9P2D1
RSPEHQPSAMSLLAP	CIT	1321	O14578
SLPHLMNPSISPAFL	RAVER2	376	Q9HCJ3
SQPPVSSATMHLPLV	MBD6	286	Q96DN6
RNSPNTSPKLMRHDP	KCNMA1	776	Q12791
PLNTPHTSANLVMTP	MGA	2586	Q8IWI9
RTSDHNSPPSLPNMR	KIAA2012	561	Q0VF49
PLTLPSPSHQLQQLM	EP400P1	36	Q6ZTU2
TTLGLQPLLPHSMTQ	LHX8	336	Q68G74
QPLLPHSMTQLPISH	LHX8	341	Q68G74
MLLRQSPTPHGLSLS	F8	811	P00451
PFLLIPMSNTTLPHT	PRNT	36	Q86SH4
MIPAEQPLSTPLSHS	ENTPD1	461	P49961
TRPTPPHLTSAMAEN	NOL4L	256	Q96MY1
LLASPCTSRPMLQHP	HIPK3	1136	Q9H422
SLSLLTMQPPALSPL	DCHS2	3331	Q6V1P9
MSHSTPRPNPSQLLL	PRSS41	296	Q7RTY9
MPSVLPSQNKPSLLH	MAML2	571	Q8IZL2
LRPNLTHSMASMPPQ	MAML2	936	Q8IZL2
LQSSLPLTISMPQGH	HABP2	331	Q14520
PCQSSHLPSTSMPLL	FAM193B	306	Q96PV7
PDQRTNSRLSHMPPL	BCL9	806	O00512
NRHSLPFSLPSQMEP	CBL	616	P22681
SMNRKLSDHPPTLPL	GRAP2	181	O75791
SPSQPHRRMSLSLPL	H6PD	721	O95479
LMNPSLSKPNISPSH	MED1	1181	Q15648
PKQMSTPCHPLRSLN	PRR14L	1591	Q5THK1
LAVSQLPPQPLMTLS	FOXN4	341	Q96NZ1
SLGHMTPVLSPQNLL	TINAGL1	246	Q9GZM7
SMSLPSSPLLPRQSH	TANC1	61	Q9C0D5
QMLSSTAILDHPPSP	MRTFA	846	Q969V6
QAPSTSVLLLSPQPM	AARS2	906	Q5JTZ9
SHRSLSPQLLQQMPS	SHANK2	441	Q9UPX8
LSLSLPSTIAAPHPM	ARAP1	301	Q96P48
TMSPLLFQAQPPSHL	SPATA31A1	461	Q5TZJ5
PPLPLMSQESLTSAQ	WDR97	781	A6NE52
SHLQPMQRPSTLPSS	TCF20	206	Q9UGU0
PSALQPPNTLMELSL	TMEM72	196	A0PK05
PNPHLKSTLAMSPRQ	PPP1R1A	56	Q13522
HSPLKRSVSLTPPMN	SAMD4A	246	Q9UPU9
STMPKHSPSPVLNRA	SPATA6	346	Q9NWH7
PSMPHQPTILLNTVS	TTLL5	926	Q6EMB2
LHTPVQPLNSSPSLR	TNRC6B	1211	Q9UPQ9